Subunit-specific modulation of glycine receptors by neurosteroids.
The effects of pregnene and androstane steroids were studied on recombinant human glycine receptors (GlyRs) by whole-cell voltage-clamp electrophysiology. The 3beta-sulphates of pregnenolone (PREGS) and dehydroepiandrosterone (DHEAS) inhibited GlyR currents with K(I) values of 2-20 microM for different (alpha(1), alpha(2), alpha(4) and beta) GlyR subunits. PREGS resulted in a parallel shift of the response curve of glycine for alpha(1) GlyRs. The inhibitory potencies of DHEAS relative to PREGS were decreased in transition from embryonic alpha(2) towards adult alpha(1)beta GlyRs. A decreased potency of DHEAS for alpha(4) versus alpha(2) GlyRs represents the first pharmacological difference reported between these subunits. A negative charge at C3 is required for GlyR antagonism but androsterone sulphate epimers at C3 inhibited without stereoselectivity. Some point mutations of alpha(1) GlyRs with characteristic functional consequences did not significantly affect the inhibitory potency of PREGS. Progesterone selectively inhibited alpha(2) GlyRs, while PREG and its acetic ester potentiated alpha(1) GlyRs. Coexpression of the alpha subunits with the beta subunit eliminated the enhancing effects of PREG and attenuated the inhibitory potencies of the neurosteroids. Based on these data we propose that neurosteroids might modulate perinatal GlyR activity and thereby influence neuronal development.
Maksay
G
G
Department of Neurochemistry, Max-Planck-Institute for Brain Research, Deutschordenstr. 46, D-60528 Frankfurt am Main, Germany. maksay@cric.chemres.hu
Laube
B
B
Betz
H
H
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D019314:Dehydroepiandrosterone Sulfate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007536:Isomerism; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects; D011283:Pregnenes / Q000494:pharmacology; D011284:Pregnenolone / Q000494:pharmacology; D018009:Receptors, Glycine / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D013237:Stereoisomerism; D013256:Steroids / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D014982:Xenopus laevis
D000731:Androstanes; D018377:Neurotransmitter Agents; D011283:Pregnenes; D018009:Receptors, Glycine; D011994:Recombinant Proteins; D013256:Steroids; D019314:Dehydroepiandrosterone Sulfate; D011284:Pregnenolone